Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)
Condition: Sickle Cell Disease · Sponsor: Medical College of Wisconsin
About this study
This is a Phase II, single arm, multi-center trial, designed to estimate the efficacy and toxicity of haploidentical bone marrow transplantation (BMT) in patients with sickle cell disease (SCD). Based on their age and entry criteria patients are stratified into two groups: (1) children with severe SCD; and (2) adults with severe SCD.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (32)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| UCSF Benioff Children's Hospital Oakland | Oakland, California, United States | — |
| University of Colorado - Denver/Children's Hospital of Colorado | Aurora, Colorado, United States | — |
| Children's National Medical Center | Washington D.C., District of Columbia, United States | — |
| University of Florida College of Medicine | Gainesville, Florida, United States | — |
| Nicklaus Children's Hospital/University of Miami Children's Hospital | Miami, Florida, United States | — |
| H. Lee Moffitt Cancer Center | Tampa, Florida, United States | — |
| Northside Hospital | Atlanta, Georgia, United States | — |
| Riley Children's Hospital at IU Health | Indianapolis, Indiana, United States | — |
| Indiana University Medical Center | Indianapolis, Indiana, United States | — |
| Johns Hopkins University | Baltimore, Maryland, United States | — |
| Children's Hospital of Michigan | Detroit, Michigan, United States | — |
+ 20 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03263559